Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Astellas Pharma Inc
Condition: Advanced Hepatocellular Carcinoma (HCC)
NCT01101906
A Randomized, Placebo-controlled, Double-blind Phase 2 Study With OSI-906 in Patients With Advanced HCC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Company decided not to pursue the development of this drug in this patient population at this time